# YARGESA
> **ANDA209821** · Abbreviated New Drug Application (Generic) · Sponsor: EDENBRIDGE PHARMS · Approved 2020-08-06
## Drug
- **FDA Application Number:** ANDA209821
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** YARGESA
- **Generic name:** MIGLUSTAT
- **Active ingredients:** MIGLUSTAT
- **Dosage form:** CAPSULE
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** EDENBRIDGE PHARMS
- **Manufacturer:** Edenbridge Pharmaceuticals LLC.
- **First approval:** 2020-08-06
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209821)
---
*MORVS · CC0 1.0*